MISSION Therapeutics raised €24M in a Series B round in Nov 2013. The company is based in Cambridge, UK. Investors in the round: Roche Venture Fund, Sofinnova Partners. Data as of 6 Aug 2026.
No source on record — unverified.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
